The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics.
We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.
While novel or innovative work is preferred, papers of a confirmatory nature will also be considered if they are scientifically and technically valid and relevant to important topics. Authors with questions as to the suitability of their manuscript should contact the journal publisher a.newman[at]elsevier.com
|Issue volume||Issue year||Planned ship date||Actual ship date|
|23C||2021||Jan 22, 2021||Jan 19, 2021|
|24C||2021||Mar 15, 2021||Mar 08, 2021|
|25C||2021||May 21, 2021||May 20, 2021|
|26C||2021||Aug 16, 2021||Aug 03, 2021|
|27C||2021||Nov 15, 2021|
|28C||2022||Jan 20, 2022|
|29C||2022||Mar 14, 2022|
|30C||2022||May 20, 2022|
|31C||2022||Aug 12, 2022|
|32C||2022||Nov 14, 2022|